Thema: US03168L1052
AMRX, US03168L1052
entrepreneur-1340649_1920.jpg - Foto: THN
Amneal Pharmaceuticals stock trades at EUR 19.20 Friday evening
Amneal Pharmaceuticals stock was quoted during Friday's evening session. The listing carries the ticker AMRX and ISIN US03168L1052.
ad-hoc-news.de, heute 19:03 Uhr
AMRX, US03168L1052
Amneal Pharmaceuticals stock hits a USD 21.46 52-week high ...
Q2 revenue rose 9.90 percent to USD 796.20 million on July 30, 2026. Amneal Pharmaceuticals stock costs EUR 19.10 on October 27, 2026.
ad-hoc-news.de, 27.10.26 21:48 Uhr
AMRX, US03168L1052
JPMorgan lifts target for Amneal Pharmaceuticals stock to ...
Amneal's Q2 revenue reached USD 796.20 million, up 9.90 percent year over year. Amneal Pharmaceuticals stock costs EUR 18.05 on October 24, 2026.
ad-hoc-news.de, 24.10.26 19:34 Uhr
AMRX, US03168L1052
Oppenheimer started coverage with USD 27.00 target for Amneal ...
Results are due November 3, 2026. Amneal Pharmaceuticals stock last stood at EUR 17.60 on October 16, 2026, down 2.22 percent versus the Tradegate close.
ad-hoc-news.de, 17.10.26 19:31 Uhr
AMRX, US03168L1052
UBS keeps USD 25.00 target for Amneal Pharmaceuticals stock ...
Results are due November 3, 2026. Amneal Pharmaceuticals stock costs EUR 17.25 on October 15, 2026.
ad-hoc-news.de, 15.10.26 21:45 Uhr
AMRX, US03168L1052
Zacks cuts Amneal Pharmaceuticals stock rating to Strong ...
Zacks cut Amneal from Hold to Strong Sell on October 8, 2026. Amneal Pharmaceuticals stock costs EUR 17.10 after EUR 17.55, down 2.56 percent.
ad-hoc-news.de, 08.10.26 16:42 Uhr
AMRX, US03168L1052
Amneal announces FDA approval and Amneal Pharmaceuticals ...
The average target is USD 22.71. Amneal Pharmaceuticals stock trades EUR 18.05 on October 7, 2026 versus EUR 18.05.
ad-hoc-news.de, 07.10.26 08:20 Uhr
